Granahan Investment Management, LLC Enanta Pharmaceuticals Inc Transaction History

Granahan Investment Management, LLC

$2.38 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$38.13 - $76.93 $1.66 Million - $3.34 Million	-43,414 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $7.96 Million - $10.5 Million	-141,997 Reduced 76.58%	43,414 $3.09 Million
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $156,193 - $252,675	2,595 Added 1.42%	185,411 $13.9 Million
Q3 2021 Nov 15, 2021	SELL	$41.02 - $58.65 $703,657 - $1.01 Million	-17,154 Reduced 8.58%	182,816 $10.4 Million
Q2 2021 Aug 16, 2021	BUY	$43.76 - $53.11 $286,803 - $348,082	6,554 Added 3.39%	199,970 $8.8 Million
Q1 2021 May 17, 2021	SELL	$41.69 - $54.95 $1.57 Million - $2.07 Million	-37,655 Reduced 16.3%	193,416 $9.54 Million
Q4 2020 Feb 12, 2021	BUY	$41.16 - $47.47 $1.77 Million - $2.04 Million	42,907 Added 22.8%	231,071 $9.73 Million
Q3 2020 Nov 12, 2020	SELL	$43.36 - $53.53 $747,352 - $922,643	-17,236 Reduced 8.39%	188,164 $8.61 Million
Q2 2020 Aug 14, 2020	BUY	$46.37 - $57.58 $2.63 Million - $3.27 Million	56,800 Added 38.22%	205,400 $10.3 Million
Q1 2020 May 12, 2020	SELL	$40.22 - $62.0 $27,872 - $42,966	-693 Reduced 0.46%	148,600 $7.64 Million
Q4 2019 Feb 14, 2020	BUY	$57.95 - $66.61 $39,927 - $45,894	689 Added 0.46%	149,293 $9.22 Million
Q3 2019 Nov 15, 2019	BUY	$60.08 - $88.17 $288,684 - $423,656	4,805 Added 3.34%	148,604 $8.93 Million
Q2 2019 Aug 14, 2019	SELL	$81.3 - $97.35 $611,619 - $732,364	-7,523 Reduced 4.97%	143,799 $12.1 Million
Q1 2019 May 14, 2019	SELL	$69.08 - $105.66 $47,319 - $72,377	-685 Reduced 0.45%	151,322 $14.5 Million
Q4 2018 Feb 13, 2019	BUY	$65.41 - $84.65 $3.18 Million - $4.12 Million	48,687 Added 47.12%	152,007 $10.8 Million
Q3 2018 Nov 13, 2018	BUY	$85.46 - $126.37 $226,468 - $334,880	2,650 Added 2.63%	103,320 $8.83 Million
Q2 2018 Aug 15, 2018	BUY	$81.85 - $120.51 $635,401 - $935,519	7,763 Added 8.36%	100,670 $11.7 Million
Q1 2018 May 14, 2018	BUY	$57.91 - $92.15 $179,289 - $285,296	3,096 Added 3.45%	92,907 $7.52 Million
Q4 2017 Feb 12, 2018	SELL	$45.65 - $59.37 $558,299 - $726,095	-12,230 Reduced 11.99%	89,811 $5.27 Million
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $3.87 Million - $4.78 Million	102,041	102,041 $4.78 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$13.4 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$12.6 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$11.8 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$9.54 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$7.03 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $132M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account